NCT05481775 2022-11-21Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung CancerSun Yat-sen UniversityPhase 2 Withdrawn
NCT02466568 2019-09-09Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the LungH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Withdrawn